Late-diagnosed phenylketonuria in an eight-year-old boy with dyslexia and attention-deficit hyperactivity disorder

Yılmaz Yıldız1, Ali Dursun1, Ayşegül Tokatlı1

  • 1Pediatric Metabolic Diseases Unit, Department of Pediatrics, Hacettepe University Faculy of Medicine, Ankara, Turkey.

Insights

Phenylketonuria (PKU) can cause cognitive and behavioral issues if not detected early. This case highlights the need for considering milder PKU phenotypes in diagnosing unexplained neurodevelopmental disorders.

Area of Science:

  • Biochemistry
  • Neuroscience
  • Genetics

Background:

  • Phenylketonuria (PKU) is a metabolic disorder historically linked to severe intellectual disability.
  • Newborn screening programs have made early diagnosis and treatment of classical PKU highly effective.
  • Untreated PKU can lead to irreversible brain damage and significant neurodevelopmental deficits.

Observation:

  • A male patient presented with dyslexia and attention-deficit hyperactivity disorder (ADHD) at eight years of age.
  • The patient was diagnosed with a mild form of phenylketonuria.
  • This diagnosis occurred significantly later than typical newborn screening.

Findings:

  • Late diagnosis of mild phenylketonuria can still impact neurobehavioral outcomes.
  • Cognitive and behavioral symptoms may indicate underlying metabolic disorders like PKU.
  • Phenylalanine hydroxylase deficiency, even in milder forms, requires consideration in differential diagnoses.

Implications:

  • Earlier recognition and intervention for phenylketonuria are crucial for optimal neurobehavioral development.
  • Expanding differential diagnoses to include milder metabolic disorders is essential for complex neurodevelopmental cases.
  • This case underscores the importance of continued vigilance for PKU beyond standard newborn screening protocols.

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
972
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
1.2K
Overview of Protein Metabolism01:21

Overview of Protein Metabolism

Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
4.4K
Learning Disabilities01:25

Learning Disabilities

Learning disabilities are cognitive disorders caused by neurological impairments that affect cognitive functions like language and reading, without indicating overall intellectual or developmental challenges. These disabilities differ from global intellectual or developmental disabilities as they are limited to distinct cognitive functions. Common learning disabilities include dysgraphia, dyslexia, and dyscalculia, each of which impacts unique aspects of learning.
Dyslexia
Dyslexia is a...
693
Pedigree Analysis01:35

Pedigree Analysis

Overview
90.4K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
306